Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-016094
Filing Date
2021-02-09
Accepted
2021-02-08 19:30:14
Documents
1
Group Members
ANTOINE PAPIERNIKDENIS LUCQUINGRAZIANO SEGHEZZIHENRIJETTE RICHTERMONIQUE SAULNIERSOFINNOVA PARTNERS SAS, A FRENCH CORP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm215409d1_sc13g.htm SC 13G 154577
  Complete submission text file 0001104659-21-016094.txt   156168
Mailing Address 50 RUE DE DIJON DAIX I0 21121
Business Address 50 RUE DE DIJON DAIX I0 21121 33380447500
Inventiva S.A. (Subject) CIK: 0001756594 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91576 | Film No.: 21603165
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7-11 BOULEVARD HAUSSMAN PARIS I0 75009
Business Address 7-11 BOULEVARD HAUSSMAN PARIS I0 75009 33 (0) 1 76 23 41 00
Sofinnova Crossover I (Filed by) CIK: 0001845105 (see all company filings)

EIN.: 981420904 | Fiscal Year End: 1231
Type: SC 13G